NCT01854593.
Trial name or title | Prospective randomized controlled study on the efficacy of 0.16 mg intravitreal bevacizumab injection for proliferative diabetic retinopathy |
Methods | Randomised, double‐masked, controlled trial |
Participants | 66 (recruitment completed August 2013) |
Interventions | Control group: sham injection and 25 gauge vitrectomy Intervention group: 0.16 mg/0.05 ml bevacizumab (single injection 1 day before operation) and 25 gauge vitrectomy |
Outcomes |
|
Starting date | May 2012 |
Contact information | Ayumu Manabe, Nihon University |
Notes | Study results on ClinicalTrials.gov |
BCVA: Best‐corrected visual acuity ETDRS: Early Treatment Diabetic Retinopathy Study PDR: proliferative diabetic retinopathy TRD: tractional retinal detachment VEGF: vascular endothelial growth factor